In Vitro Peptide Concentration: Why a Dish Value Is Not a Dose
A number such as “100 nM” in a methods section describes the liquid bathing a set of cells in a plate. It says nothing about how much of anything should go anywhere else. Understanding in vitro peptide concentration as its own unit, separate from the idea of a dose, is basic to reading the literature correctly and to writing research records that cannot be misread. This article sets out what the figures mean, why they do not translate outside the dish, and how a lab working through a large stock of research material can keep its concentration records clean.
Concentration describes a solution, not an amount given
In cell and biochemical assays, peptide quantity is expressed as concentration: moles per litre (molar), or mass per volume such as micrograms per millilitre. It is a property of a solution in a well, tube or chamber at a given moment.
A dose, in the pharmacological sense, is an amount delivered to a whole organism, normalised to something like body mass. The two are not interchangeable, and there is no conversion factor that turns one into the other. A paper reporting an EC50 of 5 nM in a reporter cell line has described how that peptide behaved in that system under those conditions. It has not described any amount appropriate for anything outside the plate, and this site does not provide such figures.
Why dish concentrations do not travel
Several features of an in-vitro system make its concentrations specific to that system:
- Flat exposure profile. Medium holds roughly the same concentration for the whole incubation. Outside a dish, concentrations rise and fall over time, so a flat line and a peak of the same height are not equivalent exposures.
- Closed volume. A well holds a fixed volume with no absorption, distribution, metabolism or clearance. The peptide stays where it was put, apart from what binds to plastic or degrades.
- Direct access. Cells in culture are exposed directly, without barriers such as tissue layers or endothelium.
- Artificial receptor levels. Engineered lines may carry far more receptor than native tissue, shifting apparent potency.
- Protein binding differs. Serum content in the medium is usually far lower than in blood, so the free fraction of a protein-binding peptide can be very different.
- Stability differs. Protease activity in culture is not the same as in any living system, in either direction.
Each of these alone breaks the link between a dish concentration and any external quantity. Together they make extrapolation meaningless without dedicated pharmacokinetic work, which is outside the scope of in-vitro research material.
Nominal versus actual in vitro peptide concentration
Even inside the dish, the concentration written in the notebook is often not the concentration the cells experience. The written figure is nominal: the amount added divided by the volume. The actual free concentration can be lower for reasons every peptide lab should anticipate.
| Source of loss or error | Effect on real concentration | Mitigation |
|---|---|---|
| Adsorption to plastic and glass | Can remove a large fraction at low nanomolar levels | Low-bind consumables, carrier protein where compatible |
| Proteolysis in medium | Falls over the incubation period | Shorter incubations, serum-reduced conditions, stability checks |
| Net peptide content below 100 percent | Weighed mass includes counter-ions and water | Correct stock calculations using net peptide content where known |
| Incomplete dissolution | Undissolved material never reaches the assay | Visual check, appropriate solvent, gentle mixing |
| Evaporation from edge wells | Concentration rises unevenly | Humidified incubation, avoid or fill edge wells |
Net peptide content matters for stock maths
A vial labelled with a mass of lyophilised peptide contains the peptide plus its counter-ion and some residual moisture. If a stock is calculated from gross weight as though it were pure peptide, every downstream concentration is overstated. Where net peptide content has been measured, stock calculations should use it, and the notebook should say which basis was used.
High concentrations are often a design choice
Many in-vitro peptide papers work at micromolar levels, even where the receptor interaction of interest has nanomolar potency. Researchers often choose high concentrations deliberately to obtain a clear signal. At a thousand-fold above the relevant potency, however, a peptide may act through mechanisms unrelated to its primary target. A reported concentration is therefore frequently an experimental setting rather than a biologically meaningful quantity, and it should be read that way.
Bridging from cells to any whole system is a specialised discipline built on measured free concentrations, binding, clearance and distribution data. For most research peptides those measurements have never been made, which is one concrete reason research-use-only restrictions are more than a formality.
Molar or mass units: pick one and state it
Molar units allow comparison across peptides of different size and are standard in receptor pharmacology. Mass-per-volume units are simpler to prepare from a weighed solid. Either is acceptable in a lab record, but mixing them causes errors, especially when comparing a short tetrapeptide to a peptide of 40 residues, where the same micrograms per millilitre represents very different molar amounts.
A practical approach is to prepare stocks by mass, record the molecular weight of the specific salt form used, and convert to molar for all assay concentrations. Keep the calculation in the record rather than just the answer.
Keeping concentration records consistent across a bulk order
A lab working through many vials of one lot will prepare many stocks over time. Small inconsistencies compound quickly across that volume. A few habits keep things tidy:
- One template for stock preparation, capturing vial ID, lot number, gross mass, net content basis, solvent, final volume and calculated concentration.
- One agreed molecular weight per product and salt form, recorded in the lab’s inventory so every user calculates from the same figure.
- Units written in full on every tube and in every table, never “10” alone.
- A check step where a second person, or a spreadsheet with locked formulas, confirms the dilution calculation before a large plate run.
When a new lot replaces an old one, the stock records make it possible to compare like with like, and to rule out arithmetic before questioning the material.
Reading the literature with the right lens
Published in-vitro papers often report concentration ranges and potency values. Read them as descriptions of that assay: that cell line, that medium, that incubation time and that readout. Before using a published value to plan your own concentration range, check whether the system is comparable. A range spanning several orders of magnitude around the literature value, with a reference compound on the same plate, is usually more informative than a single concentration borrowed from a paper.
Language matters too. Lab records, reports and internal communications should use “concentration”, “final assay concentration” or “exposure concentration” for in-vitro work, and avoid terms that imply administration to an organism. Precise wording keeps the scope of the work unambiguous for anyone who later reads the file.
All Bulk Peptides products are sold for in-vitro laboratory and analytical research only. They are not intended for human or veterinary use, and no information here should be read as guidance for such use.
